The publisher's Medical Devices sector report, 'Hematology Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update' provides comprehensive information about the Hematology pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Hematology Tests which evaluates numerous conditions involving blood and its components and the tests that generate results immediately and can be done in limited resource setting.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Hematology Tests which evaluates numerous conditions involving blood and its components and the tests that generate results immediately and can be done in limited resource setting.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Hematology under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Hematology and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment/industry
Reasons to Buy
The report enables you to:
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Hematology under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Table of Contents
1 Table of Contents
2 Introduction
3 Products under Development
4 Hematology - Pipeline Products under Development by Companies
7 Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AbSorber AB
- Aggredyne Inc
- Alba Bioscience Limited
- Amity University
- Analyticon Biotechnologies AG
- Biofortuna Ltd
- Blaze Medical Devices, LLC
- Calviri Inc
- Cellphire Inc
- Children's Hospital of Philadelphia
- CPSI Biotech
- CW Optics Inc
- Diagnostica Stago Inc
- DNA Medicine Institute (DMI) Inc
- ELITechGroup Inc
- Embryyo Technologies Pvt Ltd
- Endpoint Health Inc
- Genome Diagnostics B.V.
- Grifols SA
- Haemokinesis Pty Ltd
- Haemonetics Corp
- In Vitro Diagnostic Solutions Inc
- Indian Institute of Technology Bombay
- Instrumentation Laboratory Co
- King's College London
- Laboratorios Alpha San Ignacio Pharma S.L.
- LeukoLab
- Massachusetts General Hospital
- Medical University of Vienna
- MedPrime Technologies Pvt. Ltd.
- Mylab Discovery Solutions Pvt Ltd
- Nanospot.ai Inc
- Neuron Biopharma SA
- Northwestern University
- Ortho Clinical Diagnostics Holdings Plc
- PixCell Medical Technologies Ltd
- Plakdx LLC
- Pro Test Diagnostics AB
- Quotient Ltd
- Rapidx, Ltd.
- Redbud Labs Inc
- Sebia SA
- SiDx Inc
- Sigma Bio-Instrument Inc
- Stichting Lygature
- Streck Inc
- TBG Diagnostics Ltd
- The University of British Columbia
- Transfusion & Transplantation Technologies (Inactive)
- University of California Los Angeles
- University of Utah
- Victory Square Health Inc
- Washington University in St Louis